Denali Therapeutics Inc.DNLINASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
0.00%
↓ 100% below average
Average (38q)
391.51%
Historical baseline
Range
High:10416.82%
Low:-100.00%
Volatility
2686.2%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | -100.00% |
| Q3 2023 | -99.57% |
| Q2 2023 | 736.98% |
| Q1 2023 | 241.74% |
| Q4 2022 | 188.93% |
| Q3 2022 | -93.22% |
| Q2 2022 | 24.53% |
| Q1 2022 | 236.75% |
| Q4 2021 | 136.78% |
| Q3 2021 | -76.96% |
| Q2 2021 | 189.52% |
| Q1 2021 | -97.50% |
| Q4 2020 | 3272.88% |
| Q3 2020 | 60.65% |
| Q2 2020 | 62.24% |
| Q1 2020 | -22.86% |
| Q4 2019 | -65.66% |
| Q3 2019 | 224.14% |
| Q2 2019 | -0.19% |
| Q1 2019 | -96.65% |
| Q4 2018 | 10416.82% |
| Q3 2018 | -27.49% |
| Q2 2018 | 157.10% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |